These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 1848312)
21. Recombinants from a proviral bovine leukemia virus genome corresponding to the 3' region transactivate viral LTR in NIH3T3 and non-infected FLK cells. Noetzel U; Bauer D; Fischer U; Rosenthal S Arch Exp Veterinarmed; 1990; 44(6):901-7. PubMed ID: 1966362 [TBL] [Abstract][Full Text] [Related]
22. [Toward an unpublished method of detecting human retroviruses: activation of HIV-1 LacZ recombinant provirus by the tat gene product]. Bonnerot C; Savatier N; Nicolas JF C R Acad Sci III; 1988; 307(6):311-6. PubMed ID: 3144419 [TBL] [Abstract][Full Text] [Related]
23. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency. Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578 [TBL] [Abstract][Full Text] [Related]
24. In vivo protein binding and functional analysis of cis-acting elements in the U3 region of the bovine leukemia virus long terminal repeat. Xiao J; Buehring GC J Virol; 1998 Jul; 72(7):5994-6003. PubMed ID: 9621062 [TBL] [Abstract][Full Text] [Related]
25. Hormone regulation of bovine leukemia virus via the long terminal repeat. Niermann GL; Buehring GC Virology; 1997 Dec; 239(2):249-58. PubMed ID: 9434716 [TBL] [Abstract][Full Text] [Related]
26. An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expression. Kiermer V; Van Lint C; Briclet D; Vanhulle C; Kettmann R; Verdin E; Burny A; Droogmans L J Virol; 1998 Jul; 72(7):5526-34. PubMed ID: 9621009 [TBL] [Abstract][Full Text] [Related]
27. The bovine leukemia virus X region encodes a trans-activator of its long terminal repeat. Katoh I; Yoshinaka Y; Sagata N; Ikawa Y Jpn J Cancer Res; 1987 Feb; 78(2):93-8. PubMed ID: 3030987 [TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat. Dekoninck A; Calomme C; Nizet S; de Launoit Y; Burny A; Ghysdael J; Van Lint C Oncogene; 2003 May; 22(19):2882-96. PubMed ID: 12771939 [TBL] [Abstract][Full Text] [Related]
29. In vitro accurate transcription from the cap site of bovine leukemia virus (BLV) dependent on the BLV-infected cell nuclear lysate. Shoji-Tanaka A; Katoh I; Yoshinaka Y; Ikawa Y Virology; 1992 Oct; 190(2):834-9. PubMed ID: 1325708 [TBL] [Abstract][Full Text] [Related]
30. [Use of U3 promotor from the LTR region of bovine leukemia virus for expressing genes for antiviral antisense RNAs in cell cultures]. Borisenko AS; Shaiakhmetov DM; Gerzilova AG; Tikhonenko TI Mol Gen Mikrobiol Virusol; 1994; (3):16-20. PubMed ID: 8065378 [TBL] [Abstract][Full Text] [Related]
31. Identification of bovine leukemia virus tax function associated with host cell transcription, signaling, stress response and immune response pathway by microarray-based gene expression analysis. Arainga M; Takeda E; Aida Y BMC Genomics; 2012 Mar; 13():121. PubMed ID: 22455445 [TBL] [Abstract][Full Text] [Related]
32. Biochemical and immunological characterization of the bovine leukemia virus (BLV) envelope glycoprotein (gp51) produced in Saccharomyces cerevisiae. Legrain M; Portetelle D; Dumont J; Burny A; Hilger F Gene; 1989 Jul; 79(2):227-37. PubMed ID: 2551774 [TBL] [Abstract][Full Text] [Related]